Your browser doesn't support javascript.
loading
Patient and immunological factors associated with delayed clearance of mucosal SARS-CoV-2 RNA and symptom persistence.
Stone, Mars; Spencer, Bryan R; Warden, Donald E; Fink, Rebecca V; Saa, Paula; Leddy, Jennifer; Mulach-Vannoy, Jackie; Townsend, Rebecca; Krysztof, David; Hughes, Alexandria N; Di Germanio, Clara; Kessler, Debra A; Kleinman, Steven; Busch, Michael P; Norris, Philip J.
Afiliación
  • Stone M; Vitalant Research Institute, San Francisco, California, USA.
  • Spencer BR; Departments of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Warden DE; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Fink RV; Westat, Rockville, Maryland, USA.
  • Saa P; Westat, Rockville, Maryland, USA.
  • Leddy J; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Mulach-Vannoy J; Vitalant Research Institute, San Francisco, California, USA.
  • Townsend R; Vitalant Research Institute, San Francisco, California, USA.
  • Krysztof D; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Hughes AN; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Di Germanio C; Westat, Rockville, Maryland, USA.
  • Kessler DA; Vitalant Research Institute, San Francisco, California, USA.
  • Kleinman S; Departments of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Busch MP; New York Blood Center Enterprises, New York, New York, USA.
  • Norris PJ; University of British Columbia, Vancouver, British Columbia, Canada.
J Infect Dis ; 2024 Mar 12.
Article en En | MEDLINE | ID: mdl-38470857
ABSTRACT
Serial blood and mucosal samples were characterized for 102 participants enrolled a median of 7.0 days post-COVID-19 diagnosis. Mucosal RNA was detectable a median 31.5 (95% CI 20.5 - 63.5) days, with persistence ≥1 month associated with obesity (BMI ≥30, OR 3.9, 95% CI 1.2 - 13.8) but not age, sex, or chronic conditions. Fifteen participants had likely reinfection; lower serum anti-S IgG levels were associated with reinfection risk. Nearly half of participants (47%) reported symptoms lasting ≥2-3 months; persistence ≥3 months was associated with BMI ≥30 (OR = 4.2 95% CI 1.1 - 12.8) and peak anti-S and anti-NC antibody levels.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos